🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

12 recruiting trials

for KMT2A-rearranged

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease NCT05886049Phase 123 sites📍 Orange📍 Sacramento📍 Aventura National Cancer Institute (NCI) · Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Cytarabine, Daunorubicin Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia NCT06001788Phase 145 sites📍 Gilbert📍 Los Angeles📍 Los Angeles Kura Oncology, Inc. · Tests: Ziftomenib, Fludarabine, Idarubicin, Cytarabine, Gilteritinib Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy NCT06930352Phase 21 site📍 Columbus Uma Borate · Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Cytarabine, Echocardiography Test Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia NCT06317662Phase 2117 sites📍 Birmingham📍 Anchorage📍 Mesa National Cancer Institute (NCI) · Tests: Asparaginase Erwinia chrysanthemi, Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration, Calaspargase Pegol Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML NCT07007312Phase 3136 sites📍 Gilbert📍 Clovis📍 La Jolla Kura Oncology, Inc. · Tests: Ziftomenib, Placebo, Venetoclax, Azacitidine (AZA), Daunorubicin Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML NCT06652438Phase 3201 sites📍 Los Angeles📍 San Francisco📍 Jacksonville Stichting Hemato-Oncologie voor Volwassenen Nederland · Tests: Revumenib, Placebo Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant NCT06575296Phase 11 site📍 Duarte City of Hope Medical Center · Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Echocardiography, Electronic Health Record Review Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia NCT05327894Phase 3124 sites📍 Buenos Aires📍 Clayton📍 Adelaide Princess Maxima Center for Pediatric Oncology · Tests: Blinatumomab, Blinatumomab Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML) NCT07223814Phase 398 sites📍 Los Angeles📍 San Francisco📍 Orlando Stichting Hemato-Oncologie voor Volwassenen Nederland · Tests: Bleximenib, Cytarabine, Daunorubicin or Idarubicin, Placebo Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML NCT07355335Phase 12 sites📍 Boston📍 Boston Massachusetts General Hospital · Tests: Ziftomenib, Mezigdomide A Study of Revumenib and Mezigdomide in People With Leukemia NCT07356154Phase 1, Phase 210 sites📍 Duarte📍 Basking Ridge📍 Middletown Memorial Sloan Kettering Cancer Center · Tests: Revumenib, Mezigdomide A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML NCT07751991Phase 15 sites📍 Duarte📍 New Haven📍 Grand Rapids Charm Therapeutics · Tests: CHM-029
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy